Fox Chase Cancer Center Names New Director of Protocol Management
PHILADELPHIA (May 25, 2005) - The protocol management office at Fox Chase Cancer Center recently welcomed Linda Kish, of Philadelphia, as new director of the department. In her position, Kish will oversee and be responsible for the planning, implementing, directing and coordinating of all clinical research activities. She will also participate in ongoing employee recruitment efforts and the evaluation of possible candidates.
Prior to Fox Chase, Kish served as the Director of Clinical Trials Development for the Gynecologic Oncology Group (GOG). Kish possesses extensive experience and knowledge in all aspects of protocol development, including study activations, patient registration, regulatory compliance and industry collaboration.
Kish completed her M.S. in Quality Assessment and Regulatory Affairs at Temple University. She first received her Bachelor of Arts from Temple, graduating Summa Cum Laude.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).